Health

It's been a confusing and fast-changing couple of months for rules about getting a COVID shot. It should be a little easier now, after a panel of vaccine advisers met.

Autism isn’t a disease. It’s a complex developmental condition better known as autism spectrum disorder that affects different people in different ways.

Some studies have raised the possibility that taking acetaminophen while pregnant might up autism risk, but many others haven’t found that concern, says a Penn autism expert.

Many people start seeking vaccinations in the late summer or early fall to get protection against any winter surges in cases. Here's a closer look.

Health policy experts and long-term care operators predict that federal funding cuts will ultimately affect services for “most vulnerable” patients and residents.

Health care workers have invented devices to improve catheter insertion, prevent injuries from falls and support limbs in rehab patients.

The Northeast Public Health Collaborative has formed working groups to identify opportunities for states to share emergency public health planning and response resources.

A look at some of the recently discovered factors that shape health, disease, and survival.

The Pan-African Sisterhood Health Initiative, or P.A.S.H.I., meets every Wednesday to create reusable pads that are distributed internationally.

A growing body of research has shown that microdoses of psilocybin could be an effective tool for treating mental health illnesses.

The Young Adult Cancer Program helps address issues like fertility, relationships and finances for a group increasingly at risk.

The 2025 U.S. Asthma Capitals report identifies cities with high rates of asthma-related emergency room visits and deaths.

Mehmet Oz, the administrator of Medicare and Medicaid, has sole discretion as to the distribution of the federal funds.

The governor’s move aims to override the FDA’s action to restrict shots to people 65 or older and others with serious health issues.

Costs to Delaware patients and health insurers for GLP-1 drugs have remained flat while utilization has more than doubled in recent years.